We welcome you to Acne Treatment Center
....more
Updates on Acne Treatment With Accutane
Over 6000 Accutane Lawsuits Filed Since Drug Pulled From Shelves in 2009 - Accutane Lawsuit Center - Injury Litigation News 24/7
 Accutane Lawsuit Center - Injury Litigation News 24/7 | Over 6000 Accutane Lawsuits Filed Since Drug Pulled From Shelves in 2009 Accutane Lawsuit Center - Injury Litigation News 24/7 In 1979, Hoffman-LaRoche registered Accutane (isotretinoin) to treat acne, but the company didn't officially release Accutane to the US market until 1982. In 1985, the company released Accutane to the European market under the name Roaccutane. |
Accutane IBD: Causes, Symptoms, and Treatments - Accutane Lawsuit Center - Injury Litigation News 24/7
Accutane IBD: Causes, Symptoms, and Treatments Accutane Lawsuit Center - Injury Litigation News 24/7 The prescription drug Accutane, which was used to help treat severe acne, was withdrawn from the market in 2009 by manufacturer Hoffman-LaRoche after an increasing number of patients sought the advice of an Accutane lawyer in regard to filing an ... |
Accutane Side Effects Lawsuit Joins Multidistrict Litigation in Florida - Accutane Lawsuit Center - Injury Litigation News 24/7
 Accutane Lawsuit Center - Injury Litigation News 24/7 | Accutane Side Effects Lawsuit Joins Multidistrict Litigation in Florida Accutane Lawsuit Center - Injury Litigation News 24/7 Plaintiff Zachariah N. Donner alleges that he developed abdominal issues, including Accutane ulcerative colitis and Crohns disease, as a consequence of using the once-widely prescribed acne medication. The drug's manufacturer, Hoffmann-La Roche, ... |
Accutane Lawsuit Number Continues to Grow Despite FDA Oversight - Accutane Lawsuit Center - Injury Litigation News 24/7
Accutane Lawsuit Center - Injury Litigation News 24/7 | Accutane Lawsuit Number Continues to Grow Despite FDA Oversight Accutane Lawsuit Center - Injury Litigation News 24/7 Since that time, enough Accutane ulcerative colitis lawsuits were filed to prompt drug manufacturer Roche to pull their acne treatment off the market in 2009. In her report, Dr. Woodcock acknowledged that Accutane poses some unique challenges to both ... |
Severe acne will be focus of Research Campus study - Salisbury Post
Severe acne will be focus of Research Campus study Salisbury Post The MURDOCK Study at the Duke Translational Medicine Institute in Kannapolis is enrolling patients as young as 12 who have been diagnosed with severe acne vulgaris and have been treated with oral isotretinoin, such as Accutane, Amnesteem, ... |
